ClinicalTrials.gov
ClinicalTrials.gov Menu

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00711412
Recruitment Status : Active, not recruiting
First Posted : July 8, 2008
Last Update Posted : December 13, 2017
Sponsor:
Information provided by (Responsible Party):
Northwestern University

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : February 2018
  Estimated Study Completion Date : February 2019

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 18, 2018